Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis

ANG II-AT1 receptor pathway is involved in the anti-fibrotic effect of β-elemene

(2010) Rui Zhu et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

Rapamycin Inhibition of the Akt/mTOR Pathway Blocks Select Stages of VEGF-A 164 –Driven Angiogenesis, in Part by Blocking S6Kinase

(2009) Qi Xue et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma

(2009) B Ashleigh Guadagnolo et al.   LANCET ONCOLOGY

Tumoral Angiogenesis: Review of the Literature

(2008) Parham Khosravi Shahi et al.   CANCER INVESTIGATION

Anti-tumor effect of β-elemene in glioblastoma cells depends on p38 MAPK activation

(2008) Yi-Qun Yao et al.   CANCER LETTERS

Systemic therapy for metastatic malignant melanoma - from deeply disappointing to bright future?

(2008) Paul Lorigan et al.   EXPERIMENTAL DERMATOLOGY

Mechanisms of Metastasis: Theories Focus on Microenvironment, Host Factors, Genes

(2008) Rabiya S. Tuma   JNCI-Journal of the National Cancer Institute

Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin

(2008) Tomoya Kitamura et al.   NATURE CELL BIOLOGY

Tumor Angiogenesis

(2008) Robert S. Kerbel   NEW ENGLAND JOURNAL OF MEDICINE